October 4, 2015
Recommended Topic Related To:


"Through June of this year, the cholesterol-lowering drug rosuvastatin (Crestor, AstraZeneca) was the most prescribed branded drug in the United States, and the arthritis drug adalimumab (Humira, Abbott Laboratories) was the best-sel"...




For single-dose intraocular use only. Discard unused portion. Intraocular carbachol 0.01 % should be used with caution in patients with acute cardiac failure, bronchial asthma, peptic ulcer, hyperthyroidism, G.I. spasm, urinary tract obstruction and Parkinson's disease.


Use only if the container is undamaged.

Carcinogenesis: Studies in animals to evaluate the carcinogenic potential have not been conducted.

Pregnancy: Category C. There are no adequate and well-controlled studies in pregnant women. MIOSTAT® (carbachol intraocular solution, USP) should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Nursing mothers: It is not known if this medication is excreted in breast milk. Exercise caution when administering to a nursing woman.

Pediatric Use: Safety and efficacy in pediatric patients have not been established.

Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Last reviewed on RxList: 10/7/2008
This monograph has been modified to include the generic and brand name in many instances.


Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.